FDA to review Watson's longer-lasting cancer drug

FDA to review Watson's longer-lasting cancer drug

CNNMoney.com - 27 minutes ago
NEW YORK ( Associated Press ) - Watson Pharmaceuticals said federal health officials should make a decision on a long - lasting version of its prostate cancer drug Trelstar by third quarter 2009.The ...